T. Lebricon et al., NEGATIVE IMPACT OF CANCER-CHEMOTHERAPY ON PROTEIN-METABOLISM IN HEALTHY AND TUMOR-BEARING RATS, Metabolism, clinical and experimental, 44(10), 1995, pp. 1340-1348
Although chemotherapeutic agents are widely used in the treatment of c
ancer, few experimental data are available on their effects on host N
metabolism. We studied the effects of a single intraperitoneal (IP) in
jection of cyclophosphamide ([CYP] 120 mg/kg), 5-fluorouracil ([5-FU],
50 mg/kg), cisplatinum ([CDDP], 5 mg/kg), or methotrexate ([MTX], 30
mg/kg). N balance was studied for 6 days following chemotherapy in hea
lthy rats (0 = 40) and in rats bearing Morris Hepatoma 7777 ([MH7777]
n = 40) in a situation comparable to that of human cancer (tumor burde
n < 0.2% of body weight, moderate anorexia, and weight loss). In healt
hy rats, all drugs induced transient body weight loss, anorexia, and p
oor N balance. At day 6 posttreatment, all animals had resumed normal
feed intake and positive N balance except CDDP-treated rats, which sho
wed continued weight loss and poor N balance. CDDP and MTX exhibited a
ntitumor activity; however, CDDP induced diarrhea in six of eight tumo
r-bearing rats. Drug-induced anorexia was more severe in tumor-bearing
than in healthy treated rats. N balance was more severely decreased i
n MH7777-bearing rats than in healthy treated animals in response to 5
-FU (159 +/- 36 v 273 +/- 27 mg N/2 d) and MTX (-66 +/- 36 v 153 +/- 3
7 mg N/2d) at days 3 to 4 postinjection. These results establish the p
resence of drug-specific effects on host N balance and the existence o
f a drug-tumor interaction for N metabolism in the tumor-bearing host.
Copyright (C) 1995 by W.B. Saunders Company